Stereotactic Ablative Radiotherapy Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Int. J. Radiat. Oncol. Biol. Phys 2019 Jul 29;[EPub Ahead of Print], Y Zhang, J Schoenhals, A Christie, O Mohamad, C Wang, I Bowman, N Singla, H Hammers, K Courtney, A Bagrodia, V Margulis, N Desai, A Garant, H Choy, J Brugarolas, R Timmerman, R HannanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.